| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales | $1.81T-3.8% | $1.88T-0.9% | $1.89T+93154.2% | $2.03B+31.3% | $1.55B+36.1% | $1.14B-23.0% | $1.48B-6.5% | $1.58B+18.8% | $1.33B |
| Cost of sales | $1.45T-0.1% | $1.45T+0.4% | $1.44T+91101.6% | $1.58B+36.4% | $1.16B+37.4% | $844.1M-22.3% | $1.09B-5.4% | $1.15B+20.8% | $950.7M |
| Gross profit | $359.80B-16.1% | $428.80B-4.9% | $451.00B+100390.2% | $448.8M+16.1% | $386.6M+32.3% | $292.3M-25.0% | $389.7M-9.4% | $430.0M+13.9% | $377.6M |
| Selling, general and administrative expenses | $230.70B-3.0% | $237.80B+7.2% | $221.90B+97610.3% | $227.1M+7.9% | $210.4M+19.5% | $176.1M-14.9% | $206.9M-10.8% | $231.9M+11.8% | $207.5M |
| Research and development costs | $27.50B+1.5% | $27.10B+10.6% | $24.50B+112803.2% | $21.7M-1.4% | $22.0M+8.9% | $20.2M+1.5% | $19.9M-2.1% | $20.3M+11.9% | $18.2M |
| Loss (recovery) due to misappropriation of assets, net | -$6.90B-111.6% | $59.30B | $0 | — | — | — | — | — | — |
| Goodwill impairment | $80.80B | $0 | $0 | — | — | — | — | — | — |
| Other expense (income), net | $200.0M-89.5% | $1.90B+371.4% | -$700.0M-24237.9% | $2.9M-66.3% | $8.6M | — | — | — | — |
| Income from operations | $27.50B-73.2% | $102.70B-50.0% | $205.30B+104060.3% | $197.1M-13.7% | $228.5M+207.1% | $74.4M-49.5% | $147.2M-25.0% | $196.3M+42.4% | $137.9M |
| Interest and other financial expense, net | $62.30B+26.1% | $49.40B-2.9% | $50.90B+127468.9% | $39.9M+5.0% | $38.0M-1.8% | $38.7M+40.2% | $27.6M-3.6% | $28.6M-35.1% | $44.1M |
| Reclassification of actuarial gains from AOCI | $0 | $0+100.0% | -$8.90B | $0 | — | — | — | — | — |
| Income (loss) before earnings in affiliated companies and income taxes | -$34.80B-165.3% | $53.30B-67.4% | $163.30B+103780.4% | $157.2M-15.3% | $185.7M+619.8% | $25.8M-78.4% | $119.6M-28.7% | $167.7M+99.5% | $84.0M |
| Income tax expense | $35.80B+269.1% | $9.70B-83.9% | $60.30B+116987.4% | $51.5M-0.4% | $51.7M+538.3% | $8.1M-75.7% | $33.3M-29.1% | $46.9M+137.9% | $19.7M |
| Earnings in affiliated companies, net of tax | $500.0M-16.7% | $600.0M+20.0% | $500.0M+99900.0% | $500K-28.6% | $700K+40.0% | $500K-16.7% | $600K+1.5% | $591K+8.0% | $547K |
| Net income (loss) | -$70.10B-258.6% | $44.20B-57.3% | $103.50B+97357.6% | $106.2M-21.2% | $134.7M+640.1% | $18.2M-79.1% | $86.9M-28.4% | $121.3M+87.0% | $64.9M |
| Basic (in shares) | 56.3M-3.3% | 58.2M-1.3% | 59.0M-3.1% | 60.9M+0.3% | 60.7M+0.5% | 60.4M+0.7% | 60.0M+0.7% | 59.6M+0.4% | 59.3M |
| Diluted (in shares) | 56.3M-3.5% | 58.4M-2.7% | 60.0M-2.3% | 61.4M+0.7% | 61.0M-0.7% | 61.4M+0.2% | 61.3M+0.4% | 61.0M+0.6% | 60.7M |
| Basic (in dollars per share) | -$1.24-263.2% | $0.76-56.6% | $1.75+0.6% | $1.74-21.6% | $2.22+640.0% | $0.30-79.3% | $1.45-28.9% | $2.04+87.2% | $1.09 |
| Diluted (in dollars per share) | -$1.24-263.2% | $0.76-56.1% | $1.73+0.0% | $1.73-21.7% | $2.21+636.7% | $0.30-78.9% | $1.42-28.6% | $1.99+86.0% | $1.07 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.